66 related articles for article (PubMed ID: 23841907)
1. Interaction of phthalates and phenoxy acid herbicide environmental pollutants with intestinal intracellular lipid binding proteins.
Carbone V; Velkov T
Chem Res Toxicol; 2013 Aug; 26(8):1240-50. PubMed ID: 23841907
[TBL] [Abstract][Full Text] [Related]
2. Examination of the role of intestinal fatty acid-binding protein in drug absorption using a parallel artificial membrane permeability assay.
Velkov T; Horne J; Laguerre A; Jones E; Scanlon MJ; Porter CJ
Chem Biol; 2007 Apr; 14(4):453-65. PubMed ID: 17462580
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamics of lipophilic drug binding to intestinal fatty acid binding protein and permeation across membranes.
Velkov T
Mol Pharm; 2009; 6(2):557-70. PubMed ID: 19265444
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding promiscuity of human liver fatty acid binding protein: structural and dynamic insights from an interaction study with glycocholate and oleate.
Favretto F; Assfalg M; Gallo M; Cicero DO; D'Onofrio M; Molinari H
Chembiochem; 2013 Sep; 14(14):1807-19. PubMed ID: 23757005
[TBL] [Abstract][Full Text] [Related]
5. High relaxivity supramolecular adducts between human-liver fatty-acid-binding protein and amphiphilic Gd(III) complexes: structural basis for the design of intracellular targeting MRI probes.
D'Onofrio M; Gianolio E; Ceccon A; Arena F; Zanzoni S; Fushman D; Aime S; Molinari H; Assfalg M
Chemistry; 2012 Aug; 18(32):9919-28. PubMed ID: 22763949
[TBL] [Abstract][Full Text] [Related]
6. The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
Velkov T; Chuang S; Wielens J; Sakellaris H; Charman WN; Porter CJ; Scanlon MJ
J Biol Chem; 2005 May; 280(18):17769-76. PubMed ID: 15722357
[TBL] [Abstract][Full Text] [Related]
7. Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.
Gajda AM; Storch J
Prostaglandins Leukot Essent Fatty Acids; 2015 Feb; 93():9-16. PubMed ID: 25458898
[TBL] [Abstract][Full Text] [Related]
8. Human ketosteroid receptors interact with hazardous phthalate plasticizers and their metabolites: an in silico study.
Sarath Josh MK; Pradeep S; Vijayalekshmy Amma KS; Sudha Devi R; Balachandran S; Sreejith MN; Benjamin S
J Appl Toxicol; 2016 Jun; 36(6):836-43. PubMed ID: 26304264
[TBL] [Abstract][Full Text] [Related]
9. The unique ligand binding features of subfamily-II iLBPs with respect to bile salts and related drugs.
Favretto F; Ceccon A; Zanzoni S; D'Onofrio M; Ragona L; Molinari H; Assfalg M
Prostaglandins Leukot Essent Fatty Acids; 2015 Apr; 95():1-10. PubMed ID: 25468388
[TBL] [Abstract][Full Text] [Related]
10. Probing the fibrate binding specificity of rat liver fatty acid binding protein.
Chuang S; Velkov T; Horne J; Wielens J; Chalmers DK; Porter CJ; Scanlon MJ
J Med Chem; 2009 Sep; 52(17):5344-55. PubMed ID: 19663428
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.
Beniyama Y; Matsuno K; Miyachi H
Bioorg Med Chem Lett; 2013 Mar; 23(6):1662-6. PubMed ID: 23395658
[TBL] [Abstract][Full Text] [Related]
12. Binding kinetics of engineered mutants provide insight about the pathway for entering and exiting the intestinal fatty acid binding protein.
Richieri GV; Low PJ; Ogata RT; Kleinfeld AM
Biochemistry; 1999 May; 38(18):5888-95. PubMed ID: 10231541
[TBL] [Abstract][Full Text] [Related]
13. Chemical behavior of phthalates under abiotic conditions in landfills.
Huang J; Nkrumah PN; Li Y; Appiah-Sefah G
Rev Environ Contam Toxicol; 2013; 224():39-52. PubMed ID: 23232918
[TBL] [Abstract][Full Text] [Related]
14. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
[TBL] [Abstract][Full Text] [Related]
15. Intestinal-fatty acid binding protein and lipid transport in human intestinal epithelial cells.
Montoudis A; Delvin E; Menard D; Beaulieu JF; Jean D; Tremblay E; Bendayan M; Levy E
Biochem Biophys Res Commun; 2006 Jan; 339(1):248-54. PubMed ID: 16297872
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid binding protein 10 in the orange-spotted grouper (Epinephelus coioides): characterization and regulation under pH and temperature stress.
Qi ZH; Liu YF; Wang WN; Xin Y; Xie FX; Wang AL
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Apr; 155(3):447-55. PubMed ID: 22182678
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lipophilic drug binding to rat intestinal fatty acid binding protein.
Velkov T; Lim ML; Horne J; Simpson JS; Porter CJ; Scanlon MJ
Mol Cell Biochem; 2009 Jun; 326(1-2):87-95. PubMed ID: 19160019
[TBL] [Abstract][Full Text] [Related]
18. Characterization of critical factors influencing gene expression of two types of fatty acid-binding proteins (L-FABP and Lb-FABP) in the liver of birds.
Murai A; Furuse M; Kitaguchi K; Kusumoto K; Nakanishi Y; Kobayashi M; Horio F
Comp Biochem Physiol A Mol Integr Physiol; 2009 Oct; 154(2):216-23. PubMed ID: 19540927
[TBL] [Abstract][Full Text] [Related]
19. Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein.
Sheng N; Li J; Liu H; Zhang A; Dai J
Arch Toxicol; 2016 Jan; 90(1):217-27. PubMed ID: 25370009
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization, functional expression, tissue localization and protective potential of a Taenia solium fatty acid-binding protein.
Illescas O; Carrero JC; Bobes RJ; Flisser A; Rosas G; Laclette JP
Mol Biochem Parasitol; 2012 Dec; 186(2):117-25. PubMed ID: 23085006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
